Trump announces Agreement for Lower-Cost Weight Loss Drugs
WASHINGTON D.C. – Former President Donald Trump announced Thursday an agreement with pharmaceutical companies too considerably reduce the cost of weight-loss medications, potentially impacting millions of Americans. Under the deal, the price of weight-loss injections will drop from over $1,000 per month to around $350, while weight loss pills, still awaiting full approval, will cost $150 monthly.
The initiative, unveiled at the White House with representatives from the involved pharmaceutical companies, aims to improve public health and make these treatments more accessible. trump hailed the agreement as a “triumph for American patients,” stating it would “save lives and improve the health of millions upon millions of Americans.”
Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, echoed this sentiment, suggesting the measure coudl lead to a collective loss of 135 billion pounds among Americans by the time of the midterms – roughly a year from the announcement.
However, the ambitious projection has drawn scrutiny.With a current U.S. population of nearly 343 million, achieving Oz’s estimate would require an average weight loss of 393 pounds (approximately 178 kilograms) per person within a year.
Oz clarified that success wouldn’t solely be measured by weight loss, but also by improvements in overall health, including reduced instances of sleep apnea, joint pain, heart attacks, kidney failure, and dementia – all conditions linked to obesity.
The agreement addresses the high financial burden currently faced by overweight U.S. citizens seeking weight-loss treatments. The reduced pricing is expected to broaden access to these medications and potentially alleviate strain on the healthcare system.
